Development of curcuminoids loaded poly(butyl) cyanoacrylate nanoparticles: Physicochemical characterization and stability study

European Journal of Pharmaceutical Sciences

Volumn 37, Issue 3-4, 2009, Pages 395-404

  Mulik, Rohit ^a   Mahadik, Kakasaheb ^a   Paradkar, Anant ^b  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Bioavailability; Controlled release; Curcuminoids; Nanoparticles; Poly(butyl) cyanoacrylate; Stability

Indexed keywords

CURCUMINOID; CYANOACRYLATE; HERBACEOUS AGENT; LIPOSOME; NANOPARTICLE; POLOXAMER; POLY(BUTYL)CYANOACRYLATE; SOLVENT; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; CONTROLLED DRUG RELEASE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG STABILITY; ENCAPSULATION; ENVIRONMENT; EVAPORATION; IN VITRO STUDY; MODEL; PARTICLE SIZE; PHYSICAL CHEMISTRY; POLYMERIZATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SUNLIGHT; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ALGORITHMS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CHROMATOGRAPHY, GEL; CURCUMIN; CYANOACRYLATES; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG STABILITY; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; POLOXAMER; SOLUBILITY; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS;

EID: 67349137064     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.03.009     Document Type: Article

References (35)

1. Aggarwal, B.A., Kumar, A., Aggarwal, M.S., Shishodia, S., 2005. Curcumin derived from turmeric (Curcuma longa): a spice for all seasons. In: Phytopharmaceuticals in Cancer Chemoprevention. CRC Press LLC, pp. 349-387.
2. Anand P., Kunnumakkara A.B., Newman R.A., and Aggarwal B.A. Bioavailability of curcumin: problems and promises. Mol. Pharm. 4 (2007) 807-818
3. Ansari M.J., Ahmad S., Kohli K., Ali J., and Khar R.K. Stability indicating HPTLC determination of curcumin in bulk drug and pharmaceutical formulations. J. Pharmaceut. Biomed. Anal. 39 1-2 (2005) 132-138
4. Behan N., Birkinshaw C., and Clarke N. Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation. Biomaterials 22 (2001) 1335-1344
5. Bong P.H. Spectral and photophysical behaviors of curcumin and curcuminoids. Bull. Korean Chem. Soc. 21 1 (2000) 81-86
6. Chattopadhyay I., Biswas K., Bandyopadhyay U., and Banerjee R.K. Turmeric and curcumin: biological actions and medicinal applications. Curr. Sci. 87 1 (2004) 44-53
7. Couvreur P., Fattal E., Alphandary H., Puisieux F., and Andremont A. Intracellular targeting of antibiotics by means of biodegradable nanoparticles. J. Control. Rel. 19 (1992) 259-268
8. Couvreur P., Dubernet C., and Puisieux F. Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur. J. Pharm. Biopharm. 41 (1995) 2-13
9. Damge C., Michel C., Aprahamian M., Couvreur P., and Devissaguet J.P. Nanoparticles as carriers for oral peptide delivery. J. Control. Rel. 13 (1990) 233-239
10. Dhavale D.D., and Jachak S.M. The 5-endo-trig cyclization of D-glucose derived γ-alkenylamines with mercury(II) salts: synthesis of 1-deoxycastanospermine and its 8a-epi-analogue. Molecules 10 (2005) 893-900
11. Douglas S.J., Illum L., Davis S.S., and Kreuter J. Particle size and size distribution of poly(butyl 2-cyanoacrylate) nanoparticles. I. Influence of physicochemical factors. J. Colloid Interface Sci. 101 (1984) 149-158
12. Douglas S.J., Illum L., Davis S.S., and Kreuter J. Particle size and size distribution of poly(butyl 2-cyanoacrylate) nanoparticles. II. Influence of stabilizers. J. Colloid Interface Sci. 103 (1985) 154-163
13. Huang C.Y., and Lee Y.D. Core-shell type of nanoparticles composed of poly[(n-butyl cyanoacrylate)-co-(2-octyl cyanoacrylate)] copolymers for drug delivery application: synthesis, characterization and in vitro degradation. Int. J. Pharm. 325 (2006) 132-139
14. Huang C.Y., Chen C.M., and Lee Y.D. Synthesis of high loading and encapsulation efficient paclitaxel-loaded poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion. Int. J. Pharm. 338 (2007) 267-275
15. Illum L., Khan M.A., Mak E., and Davis S.S. Evaluation of carrier capacity and release characteristics for poly(butyl 2-cyanoacrylate) nanoparticles. Int. J. Pharm. 30 (1986) 17-28
16. Kreuter J. Nanoparticle based drug delivery systems. J. Control. Rel. 16 (1991) 169-176
17. Marchal H.I., Maincent P., Hoffman M., Spittler J., and Couvreur P. Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutyl cyanoacrylate nanoparticle preparations. Int. J. Pharm. 58 (1990) 115-122
18. Miyazaki S., Takahashi A., and Kubo W. Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration. J. Pharm. Pharmaceut. Sci. 6 2 (2003) 240-245
19. Muller R.H., Lherm C., Herbot J., Blunk T., and Couvreur P. Alkylcyanoacrylate drug carriers. I. Physicochemical characterization of nanoparticles with different chain length. Int. J. Pharm. 84 (1992) 1-11
20. Padamwar M.N., and Pokharkar V.B. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability. Int. J. Pharm. 320 (2006) 37-44
21. Page-Clisson M.E., Pinto-Alphandary H., Ourevitch M., Andremont A., and Couvreur P. Development of ciprofloxacin-loaded nanoparticles: physicochemical study of the drug carrier. J. Control. Rel. 56 (1998) 23-32
22. Petri B., Bootz A., Khalansky A., Hekmatara T., Müller R., Uhl R., Kreuter J., and Gelperina S. Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. J. Control. Rel. 117 (2007) 51-58
23. Pirker S., Kruse J., Noe C., Langer K., Zimmer A., and Kreuter J. Characterization of polybutyleyanoacrylate nanoparticles. Part II. Determination of polymer content by NMR-analysis. Int. J. Pharm. 128 (1996) 189-195
24. Reddy L.H., and Murthy R.S.R. Influence of polymerization technique and experimental variables on the particle properties and release kinetics of methotrexate from poly(butylcyanoacrylate) nanoparticles. Acta Pharm. 54 (2004) 103-118
25. Reddy L.H., and Murthy R.S.R. Study of influence of polymerization factors on formation of poly(butyl cyanoacrylate) nanoparticles and in vitro drug release kinetics. Ars. Pharm. 45 3 (2004) 211-234
26. Salgueiro A., Gamisans F., Espina M., Alcober X., Garci{dotless}a M.L., and Egea M.A. Cyclophosphamide-loaded nanospheres: analysis of the matrix structure by thermal and spectroscopic methods. J. Microencapsul. 19 (2002) 305-310
27. Sommerfeld P., Schroeder U., and Sabel B.A. Long-term stability of PBCA nanoparticle suspensions suggests clinical usefulness. Int. J. Pharm. 155 (1997) 201-207
28. Sullivan C.O., and Birkinshaw C. In vitro degradation of insulin-loaded poly(n-butylcyanoacrylate) nanoparticles. Biomaterials 25 (2004) 4375-4382
29. Tasset C., Barette N., Thysman S., Ketelslegers J.M., Lemoine D., and Preat V. Polyisobutylcyanoacrylate nanoparticles as sustained release system for calcitonin. J. Control. Rel. 33 (1995) 23-30
30. Tiyaboonchaia W., Tungpradita W., and Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int. J. Pharm. 337 1-2 (2007) 299-306
31. Tonnesen H.H., and Karlsen J. Studies on curcumin and curcuminoids. VI. Kinetics of curcumin degradation in aqueous solution. Z. Lebensm. Unters. Forsch. 180 5 (1985) 402-404
32. Tonnesen H.H., Masson M., and Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation solubility, chemical, and photochemical stability. Int. J. Pharm. 244 (2002) 127-135
33. Vauthier C., Dubernet C., Chauvierre C., Brigger I., and Couvreur P. Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles. J. Control. Rel. 93 (2003) 151-160
34. Vauthier C., Dubernet C., Fattal E., Pinto-Alphandary H., and Couvreur P. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv. Drug Deliv. Rev. 55 (2003) 519-548
35. Zhang J.F., Hou S.X., and Liu H.L. Comparison of preparing two polylactide nanoparticles loaded lipophilic anti-cancer herb drug by nanoprecipitation method. China J. Chin. Mater. Med. 32 4 (2007) 303-306